loadpatents
Patent applications and USPTO patent grants for Gewirtz; Alan M..The latest application filed is for "methods of use of bcl-6-derived nucleotides to induce apoptosis".
Patent | Date |
---|---|
Methods of use of bcl-6-derived nucleotides to induce apoptosis Grant 7,851,452 - Gewirtz December 14, 2 | 2010-12-14 |
Methods of Use of Bcl-6-Derived Nucleotides to Induce Apoptosis App 20080153765 - Gewirtz; Alan M. | 2008-06-26 |
HIV-MSCV hybrid viral vector for gene transfer Grant 6,218,186 - Choi , et al. April 17, 2 | 2001-04-17 |
Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides Grant 5,652,222 - Calabretta , et al. July 29, 1 | 1997-07-29 |
Selective inhibition of cell proliferation by vav antisense oligonucleotides Grant 5,612,212 - Gewirtz March 18, 1 | 1997-03-18 |
Method for predicting the effectiveness of antineoplastic therapy in individual patients Grant 5,427,916 - Gewirtz , et al. June 27, 1 | 1995-06-27 |
Antisence oligonucleotides to c-myb proto-oncogene and uses thereof Grant 5,098,890 - Gewirtz , et al. March 24, 1 | 1992-03-24 |
NCAGE Code | 4ELM6 | GEWIRTZ ALAN M |
CAGE Code | 4ELM6 | GEWIRTZ, ALAN M |
DUNS | 625350249 | GEWIRTZ, ALAN M |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.